223 related articles for article (PubMed ID: 35341712)
1. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study.
Faghri F; Brunn F; Dadu A; ; ; Zucchi E; Martinelli I; Mazzini L; Vasta R; Canosa A; Moglia C; Calvo A; Nalls MA; Campbell RH; Mandrioli J; Traynor BJ; Chiò A
Lancet Digit Health; 2022 May; 4(5):e359-e369. PubMed ID: 35341712
[TBL] [Abstract][Full Text] [Related]
2. Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.
Tang M; Gao C; Goutman SA; Kalinin A; Mukherjee B; Guan Y; Dinov ID
Neuroinformatics; 2019 Jul; 17(3):407-421. PubMed ID: 30460455
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study.
Ferraro D; Consonni D; Fini N; Fasano A; Del Giovane C; ; Mandrioli J
Eur J Neurol; 2016 Sep; 23(9):1426-32. PubMed ID: 27238551
[TBL] [Abstract][Full Text] [Related]
5. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
;
Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
[TBL] [Abstract][Full Text] [Related]
8. Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data.
Marriott H; Kabiljo R; Hunt GP; Khleifat AA; Jones A; Troakes C; ; ; Pfaff AL; Quinn JP; Koks S; Dobson RJ; Schwab P; Al-Chalabi A; Iacoangeli A
Acta Neuropathol Commun; 2023 Dec; 11(1):208. PubMed ID: 38129934
[TBL] [Abstract][Full Text] [Related]
9. Video-Based Facial Movement Analysis in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Clinical Validation.
Guarin DL; Taati B; Abrahao A; Zinman L; Yunusova Y
J Speech Lang Hear Res; 2022 Dec; 65(12):4667-4678. PubMed ID: 36367528
[TBL] [Abstract][Full Text] [Related]
10. Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries.
Martinelli I; Ghezzi A; Zucchi E; Gianferrari G; Ferri L; Moglia C; Manera U; Solero L; Vasta R; Canosa A; Grassano M; Brunetti M; Mazzini L; De Marchi F; Simonini C; Fini N; Vinceti M; Pinti M; Chiò A; Calvo A; Mandrioli J
J Neurol; 2023 Dec; 270(12):6081-6092. PubMed ID: 37668704
[TBL] [Abstract][Full Text] [Related]
11. Staging model for amyotrophic lateral sclerosis in Singapore.
Tay YT; H Chai JY; Shekh Jabin KB; Ang K
Singapore Med J; 2022 Jul; 63(7):371-375. PubMed ID: 33472335
[TBL] [Abstract][Full Text] [Related]
12. Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.
Chiò A; Mora G; Moglia C; Manera U; Canosa A; Cammarosano S; Ilardi A; Bertuzzo D; Bersano E; Cugnasco P; Grassano M; Pisano F; Mazzini L; Calvo A;
JAMA Neurol; 2017 Sep; 74(9):1097-1104. PubMed ID: 28692730
[TBL] [Abstract][Full Text] [Related]
13. Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning.
Founta K; Dafou D; Kanata E; Sklaviadis T; Zanos TP; Gounaris A; Xanthopoulos K
Mol Med; 2023 Jan; 29(1):12. PubMed ID: 36694130
[TBL] [Abstract][Full Text] [Related]
14. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
15. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.
Thakore NJ; Lapin BR; Kinzy TG; Pioro EP
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):483-494. PubMed ID: 30001159
[TBL] [Abstract][Full Text] [Related]
16. Utility of the ALSFRS-R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank.
Colvin LE; Foster ZW; Stein TD; Thakore-James M; Salajegheh MK; Carr K; Spencer KR; Abdul Rauf N; Adams L; Averill JG; Walker SE; Robey I; Alvarez VE; Huber BR; McKee AC; Kowall NW; Brady CB
Muscle Nerve; 2022 Aug; 66(2):167-174. PubMed ID: 35585776
[TBL] [Abstract][Full Text] [Related]
17. Ocular Involvement Occurs Frequently at All Stages of Amyotrophic Lateral Sclerosis: Preliminary Experience in a Large Italian Cohort.
Cozza F; Lizio A; Greco LC; Bona S; Donvito G; Carraro E; Tavazzi S; Ticozzi N; Poletti B; Sansone VA; Lunetta C
J Clin Neurol; 2021 Jan; 17(1):96-105. PubMed ID: 33480204
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review.
Tavazzi E; Longato E; Vettoretti M; Aidos H; Trescato I; Roversi C; Martins AS; Castanho EN; Branco R; Soares DF; Guazzo A; Birolo G; Pala D; Bosoni P; Chiò A; Manera U; de Carvalho M; Miranda B; Gromicho M; Alves I; Bellazzi R; Dagliati A; Fariselli P; Madeira SC; Di Camillo B
Artif Intell Med; 2023 Aug; 142():102588. PubMed ID: 37316101
[TBL] [Abstract][Full Text] [Related]
20. Natural history and clinical features of the flail arm and flail leg ALS variants.
Wijesekera LC; Mathers S; Talman P; Galtrey C; Parkinson MH; Ganesalingam J; Willey E; Ampong MA; Ellis CM; Shaw CE; Al-Chalabi A; Leigh PN
Neurology; 2009 Mar; 72(12):1087-94. PubMed ID: 19307543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
